BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38164630)

  • 1. Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis.
    Dou Y; Zhang L; Liu Y; He M; Wang Y; Wang Z
    Int J Hyperthermia; 2024; 41(1):2299479. PubMed ID: 38164630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
    Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
    Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of ultrasound guided high intensity focused ultrasound ablation for patients with uterine fibroids classified by T2WI: a multicenter retrospective study.
    Yuan Y; Xu W; Shen H; Lin Z; Xu F; Shi Q; Zhan P; Liu M; Shu J; Chen J; Xing HR
    Int J Hyperthermia; 2023; 40(1):2212887. PubMed ID: 37202174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
    Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
    BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids.
    Li W; Jiang Z; Deng X; Xu D
    Int J Hyperthermia; 2020; 37(1):1046-1051. PubMed ID: 32878497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
    Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
    Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids.
    Wei C; Li N; Shi B; Wang C; Wu Y; Lin T; Chen Y; Ge Y; Yu Y; Dong J
    Int J Hyperthermia; 2022; 39(1):475-484. PubMed ID: 35271784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates.
    Ikink ME; Nijenhuis RJ; Verkooijen HM; Voogt MJ; Reuwer PJ; Smeets AJ; Lohle PN; van den Bosch MA
    Eur Radiol; 2014 Oct; 24(10):2649-57. PubMed ID: 25117743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
    Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
    Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids with the volume <300 cm
    Yu L; Zhu S; Zhang H; Wang A; Sun G; Liang J; Wang X
    Int J Hyperthermia; 2021; 38(1):1126-1132. PubMed ID: 34325610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of postoperative reintervention risk for uterine fibroids using clinical-imaging features and T2WI radiomics before high-intensity focused ultrasound ablation.
    Qin S; Lin Z; Liu N; Zheng Y; Jia Q; Huang X
    Int J Hyperthermia; 2023; 40(1):2226847. PubMed ID: 37394476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.
    Lyon PC; Rai V; Price N; Shah A; Wu F; Cranston D
    Ultraschall Med; 2020 Oct; 41(5):550-556. PubMed ID: 31238385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images.
    Wang Y; Gong C; He M; Lin Z; Xu F; Peng S; Zhang L
    Int J Hyperthermia; 2023; 40(1):2194594. PubMed ID: 37011910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
    Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
    Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy.
    Verpalen IM; de Boer JP; Linstra M; Pol RLI; Nijholt IM; Moonen CTW; Bartels LW; Franx A; Boomsma MF; Braat MNG
    Eur Radiol; 2020 May; 30(5):2473-2482. PubMed ID: 32040725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.
    Fan HJ; Cun JP; Zhao W; Huang JQ; Yi GF; Yao RH; Gao BL; Li XH
    Int J Hyperthermia; 2018; 35(1):534-540. PubMed ID: 30428735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation.
    Zhao WP; Chen JY; Chen WZ
    Ultrasound Med Biol; 2015 Feb; 41(2):423-31. PubMed ID: 25542494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles?
    Orsi F; Monfardini L; Bonomo G; Krokidis M; Della Vigna P; Disalvatore D
    Int J Hyperthermia; 2015 May; 31(3):233-9. PubMed ID: 25758436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study.
    Li W; Yang Z; Gao B; Zou L; Xu D; Liu L; Gu P; Deng X
    Int J Hyperthermia; 2021; 38(1):1609-1616. PubMed ID: 34763580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.